Cargando…

CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis

Drug resistance occurs frequently in triple-negative breast cancer (TNBC) and leads to early relapse and short survival. Targeting the DNA damage response (DDR) has become an effective strategy for overcoming TNBC chemoresistance. CENPF (centromere protein) is a key regulator of cell cycle progressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Depeng, Xu, Wei, Huang, Minghua, Ma, Wei, Liu, Yulu, Zhou, Xingchen, Yang, Qingrui, Mu, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889717/ https://www.ncbi.nlm.nih.gov/pubmed/36720923 http://dx.doi.org/10.1038/s41598-023-28355-z

Ejemplares similares

Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway
por: Hexiao, Tang, et al.
Publicado: (2021)

HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis
por: Chen, Er-Bao, et al.
Publicado: (2019)

Upregulation of CENPF is linked to aggressive features of osteosarcoma
por: Zou, Ping-An, et al.
Publicado: (2021)

[Retracted] Upregulation of CENPF is linked to aggressive features of osteosarcoma
por: Zou, Ping-An, et al.
Publicado: (2023)

Centromere Protein F (CENPF): A novel marker for salivary gland pathology
por: Lakshmi, T. A, et al.
Publicado: (2022)

Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer
por: Lin, Shih-Chieh, et al.
Publicado: (2016)

CENPF promotes the proliferation of renal cell carcinoma in vitro
por: Zhang, Ji, et al.
Publicado: (2023)

Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma
por: Huang, Yugang, et al.
Publicado: (2021)

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
por: Sun, Jingbo, et al.
Publicado: (2019)

The kinetochore protein, CENPF, is mutated in human ciliopathy and microcephaly phenotypes
por: Waters, Aoife M, et al.
Publicado: (2015)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Frequent Amplification of CENPF, GMNN and CDK13 Genes in Hepatocellular Carcinomas
por: Kim, Hye-Eun, et al.
Publicado: (2012)

Erratum: The kinetochore protein, CENPF, is mutated in human ciliopathy and microcephaly phenotypes
Publicado: (2016)

Role of CCNB1, CENPF, and neutrophils in lung cancer diagnosis and prognosis
por: Tan, Feixiang, et al.
Publicado: (2023)

The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells
por: Jelly, Neil D, et al.
Publicado: (2012)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

Knockdown of SPON2 inhibits the growth of triple-negative breast cancer
por: Hu, Xueyi, et al.
Publicado: (2023)

TOP2A and CENPF are synergistic master regulators activated in cervical cancer
por: Yu, Beiwei, et al.
Publicado: (2020)

CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
por: Han, Yong, et al.
Publicado: (2021)

Biallelic variants in CENPF causing a phenotype distinct from Strømme syndrome
por: Cappuccio, Gerarda, et al.
Publicado: (2022)

CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
por: Shrestha, Mariusz, et al.
Publicado: (2023)

Retraction: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells
por: Jelly, Neil D, et al.
Publicado: (2013)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis
por: Chen, Fengxia, et al.
Publicado: (2021)

Novel strategies to target chemoresistant triple-negative breast cancer
por: Venkatesh, Jaganathan, et al.
Publicado: (2020)

DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
por: Ogbu, Stella C., et al.
Publicado: (2021)

IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
por: Liao, Jian, et al.
Publicado: (2023)

XBP1 negatively regulates CENPF expression via recruiting ATF6α to the promoter during ER stress
por: Shen, Tao, et al.
Publicado: (2020)

Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: Involvement of the RB-microRNA axis
por: Liu, Xianpeng, et al.
Publicado: (2014)

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer
por: Wang, Wei, et al.
Publicado: (2023)

Identification of potential key genes and functional role of CENPF in osteosarcoma using bioinformatics and experimental analysis
por: Ma, Yihui, et al.
Publicado: (2022)

CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma
por: Li, Mengzhi, et al.
Publicado: (2022)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

Suppression of KIF3A inhibits triple negative breast cancer growth and metastasis by repressing Rb‐E2F signaling and epithelial‐mesenchymal transition
por: Wang, Weilin, et al.
Publicado: (2020)

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
por: Si, Wentao, et al.
Publicado: (2022)

Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular Carcinoma
por: Ho, Daniel Wai-Hung, et al.
Publicado: (2022)

FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma
por: Li, Peipei, et al.
Publicado: (2023)

Novel Loss of Function Variants in CENPF Including a Large Intragenic Deletion in Patients with Strømme Syndrome
por: Misceo, Doriana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hrcpkbgk2b8og9ld3lao9101q9